Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study
暂无分享,去创建一个
A. el-Zayadi | H. Badran | E. Barakat | M. Attia | O. Selim | Hassan Khaled Hamdy | A. El-Tawil | A. Saied | A. El-Nakeeb | A. El‐Zayadi